Market Size of HbA1c Testing Industry
| Study Period | 2018-2029 |
| Market Size (2024) | USD 1 Billion |
| Market Size (2029) | USD 1 Billion |
| CAGR (2024 - 2029) | 1.00 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
HbA1c Testing Market Analysis
The HbA1c Testing Market size is estimated at USD 1 billion in 2024, and is expected to reach USD 1 billion by 2029, growing at a CAGR of 1% during the forecast period (2024-2029).
People with diabetes mellitus had a greater risk of contracting COVID-19 infection. Various studies suggested that type-2 diabetes mellitus patients had increased chances of pulmonary damage following SARS-COV-2 infection. The hyperglycemic state was an important prognostic factor in diabetic patients exposed to SARS-CoV-2. HbA1c was the only predictor of COVID‐19 hospitalization among other chronic health conditions, and the risk for hospitalization increased at HbA1c ≥ 8%, which suggested its pathogenic importance and clinical utility. Therefore, the urgent need to control elevated blood glucose control gave a boost to the market during the pandemic.
HbA1c is measured to determine the three-month average blood sugar level and can be used as a diagnostic test for diabetes mellitus. It is also an assessment test for glycemic control in people with diabetes. The test is limited to a three-month average because the average lifespan of a red blood cell is four months. In diabetes, higher amounts of glycated hemoglobin indicate poorer control of blood glucose levels and have been associated with cardiovascular disease, nephropathy, neuropathy, and retinopathy.
The HbA1c Test is an accurate and easy-to-administer test and can be an effective tool in the diagnosis of diabetes. A combination of the Fasting glucose test and HbA1c test enhances the diagnostic accuracy of individual tests. The HbA1c test helps in glycemic control and predicts the lipid profile in diabetic patients. Due to increasing diabetes prevalence worldwide, the HbA1c test market is expected to continuously grow as part of the diagnostic and prognostic tool, leading to better patient care and clinical outcomes.
Furthermore, Government initiatives such as the roll-out of the world’s first program to transform diabetes care for people under 40 in August 2023 by NHS, in which around 140,000 people aged 18 to 39 years old will likely receive additional tailored health checks from healthcare staff, and support with diabetes management, such as blood sugar level control, weight management, and cardiovascular risk minimization are likely to facilitate the market growth over the forecast period. The NHS is the first health system in the world to put in place a national, targeted program for high-risk groups of people.
HbA1c Testing Industry Segmentation
The HbA1c test is a blood test used to determine the average blood sugar level over two to three months. The HbA1c testing market is segmented by type (handheld device, benchtop device), by end-user (hospitals and clinics, diagnostic laboratories, other end-users), and by geography (North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America).
The report offers the value (in USD) for the above segments.
| Type | |
| Handheld device | |
| Benchtop device |
| End-User | |
| Hospitals and Clinics | |
| Diagnostic Laboratories | |
| Other End-Users |
| Geography | |||||||||||||
| |||||||||||||
| |||||||||||||
| |||||||||||||
| |||||||||||||
|
HbA1c Testing Market Size Summary
The HbA1c testing market is poised for steady growth over the forecast period, driven by the increasing prevalence of diabetes globally. This market is characterized by its role in diagnosing and monitoring diabetes through the measurement of glycated hemoglobin, which reflects average blood sugar levels over the past three months. The test's clinical utility was underscored during the COVID-19 pandemic, where elevated HbA1c levels were linked to higher hospitalization risks, thereby boosting demand. The market is further supported by government initiatives aimed at improving diabetes care and management, such as the NHS program targeting young adults, which emphasizes blood sugar control and cardiovascular risk reduction. The integration of HbA1c testing with other diagnostic tools, like fasting glucose tests, enhances its accuracy and effectiveness in patient care.
Regionally, the Asia-Pacific market is expected to experience significant growth, driven by the rising diabetic population in countries like India and China. These markets face challenges such as economic constraints and competition, necessitating effective diabetes management strategies. The region's healthcare systems are increasingly prioritizing diabetes care, with initiatives like the establishment of National Metabolic Management Centers in China and comprehensive medical insurance coverage in Japan. The market is fragmented, with key players like Abbott, Roche, and Bio-Rad Laboratories focusing on innovation and technological advancements in HbA1c testing methods. Recent developments, such as point-of-care devices and non-invasive testing approaches, are expected to further propel market growth, alongside strategic collaborations and product launches aimed at expanding market reach and improving access to testing, particularly in low and middle-income countries.
HbA1c Testing Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Drivers
-
1.3 Restraints
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Bargaining Power of Suppliers
-
1.4.2 Bargaining Power of Consumers
-
1.4.3 Threat of New Entrants
-
1.4.4 Threat of Substitute Products and Services
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 Type
-
2.1.1 Handheld device
-
2.1.2 Benchtop device
-
-
2.2 End-User
-
2.2.1 Hospitals and Clinics
-
2.2.2 Diagnostic Laboratories
-
2.2.3 Other End-Users
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Rest of North America
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 Spain
-
2.3.2.3 Italy
-
2.3.2.4 France
-
2.3.2.5 United Kingdom
-
2.3.2.6 Russia
-
2.3.2.7 Rest of Europe
-
-
2.3.3 Asia-Pacific
-
2.3.3.1 Japan
-
2.3.3.2 China
-
2.3.3.3 Australia
-
2.3.3.4 India
-
2.3.3.5 South Korea
-
2.3.3.6 Malaysia
-
2.3.3.7 Indonesia
-
2.3.3.8 Thailand
-
2.3.3.9 Philippines
-
2.3.3.10 Vietnam
-
2.3.3.11 Rest of Asia-Pacific
-
-
2.3.4 Latin America
-
2.3.4.1 Brazil
-
2.3.4.2 Mexico
-
2.3.4.3 Rest of Latin America
-
-
2.3.5 Middle East and Africa
-
2.3.5.1 South Africa
-
2.3.5.2 Saudi Arabia
-
2.3.5.3 Oman
-
2.3.5.4 Egypt
-
2.3.5.5 Iran
-
2.3.5.6 Rest of Middle East and Africa
-
-
-
HbA1c Testing Market Size FAQs
How big is the HbA1c Testing Market?
The HbA1c Testing Market size is expected to reach USD 1 billion in 2024 and grow at a CAGR of 1% to reach USD 1 billion by 2029.
What is the current HbA1c Testing Market size?
In 2024, the HbA1c Testing Market size is expected to reach USD 1 billion.
